Immunostimulatory oligonucleotide multimers
US7405285B2 · kind B2 · utility
23Cited by
6References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 2005 |
| Grant date | Jul 29, 2008 |
| Priority date | — |
| Expiry date | Nov 4, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3519
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides an immunostimulatory nucleic acid. In certain embodiments according to this aspect of the invention, the sequence of the immunostimulatory oligonucleotide and/or immunomer is at least partially self-complementary.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.